World Health Organization (WHO) Provides Urgent Medical Support to Ghana to Combat Meningitis Outbreak
As cases increased from 42 to 60, with 14 reported deaths, WHO donated 10,600 vials of Ceftriaxone, a potent antibiotic used in meningitis treatment. The donation, valued at approximately $23,000, was officially received by the Minister of Health, Hon. Kwabena Mintah Akandoh, at a brief ceremony in Accra. The Minister immediately handed over the vials to the Director-General of the Ghana Health Service (GHS), Prof. Samuel Kaba Akoriyea, for swift deployment to affected communities.
Speaking at the handing over of the items, Dr. Frank Lule, Officer in Charge of WHO Ghana, reaffirmed WHO's commitment to Ghana's health systems. He said, 'This donation is another testament to WHO's commitment to strengthening Ghana's health systems. If additional vials are needed, we will be here to provide more support.'
Hon. Kwabena Mintah Akandoh, Minister of Health, emphasized the importance of WHO's support, saying: 'We are currently managing several outbreaks, and this timely donation is crucial. I'm about to brief Ghana's Parliament on our response and will highlight WHO's support.'
In addition to medical supplies, WHO has dispatched Dr. Nicolō Binello, a Technical Officer specializing in Meningitis and Epidemic Bacterial Diseases from its headquarters in Geneva. Dr. Binello will work closely with national and local health authorities to strengthen clinical care and response strategies, ensuring effective treatment for patients and mitigating further spread of the disease.
Prof. Samuel Kaba Akoriyea, Director-General of Ghana Health Service, assured that the donation would be put to immediate use. 'This donation will go directly to the affected areas. WHO has also deployed a technical officer to support Ghana's meningitis response. We are truly grateful', he said.
As part of its response, the Ghana Health Service has intensified public education campaigns, urging citizens to seek medical care at the earliest signs of meningitis symptoms. Additionally, treatment for meningitis is being offered free of charge in all health facilities to eliminate financial barriers and reduce mortality rates.
The ongoing collaboration between WHO, Ghanaian health authorities, and local communities highlights a unified commitment to addressing the meningitis outbreak. Through strategic interventions, expert deployment, and resource mobilization, efforts are being intensified to curb the disease and safeguard public health.
Distributed by APO Group on behalf of WHO Regional Office for Africa.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
3 hours ago
- Zawya
A breastfeeding space at World Health Organization (WHO) Uganda country office: Upholding every woman and baby's right to breastfeed anytime, anywhere
Invest in breastfeeding, invest in the future! Breastfeeding isn't just a personal choice—it's a public health investment. Breast milk nurtures stronger immune systems, reduces childhood illnesses and supports lifelong health, that reduces burdens on health systems. By supporting breastfeeding at work, we are building healthier families, communities, and workforces. At the World Health Organization (WHO) Uganda country office, we believe that supporting working mothers is not just a policy—it's a promise. In line with global health recommendations from WHO and UNICEF, we proudly introduce a dedicated breastfeeding space for staff and visitors, designed to promote optimal infant nutrition and maternal wellbeing. "The breastfeeding room is a small gesture with a big impact here at the country office. It shows that our workplace truly cares about family-friendly policies." said Mr Christopher Chikombero, the operations officer at WHO Uganda. Exclusive breastfeeding for the first six months, followed by continued breastfeeding up to two years, is a cornerstone of child health. Yet for many working mothers, balancing this with professional responsibilities is a daily challenge. Our breastfeeding space offers a private, quiet, comfortable, and hygienic environment for mothers to express and store breast milk or breastfeed during the workday—reducing stress, enhancing comfort, and supporting both mother and child. "Having a dedicated breastfeeding room at office is such an incredible resource. It's a quiet, clean, and private space where I can express milk comfortably. It helps me balance work and motherhood without stress." said Dr Solome Okware, surveillance officer at WHO Uganda. No woman should have to choose between her career and her child's health. Breastfeeding support is possible in every workplace, across all sectors and contract types. By creating this safe and nurturing environment for mothers and their babies, WHO Uganda joins the global movement to ensure that breastfeeding and work, work. "Returning to work after maternity leave was smoother because I knew I had a safe space to continue breastfeeding. As a working mother, I feel seen, valued and supported,' said Ms Maria Mugisa, logistics assistant at WHO Uganda. At WHO Uganda, we recognize that empowering women through breastfeeding support is not just a workplace initiative—it's a commitment to health equity, gender inclusion, and sustainable development. The breastfeeding space is more than a room—it's a reflection of our values, a catalyst for change, and a step toward a healthier, more compassionate future for all. Distributed by APO Group on behalf of World Health Organization - Uganda.
The National
4 hours ago
- The National
Biometric rules delay evacuation of Gaza children to UK
Up to 50 children from Gaza could be evacuated to the UK for medical treatment by the end of the month, but biometric hurdles mean the most serious cases may not make it. The children will receive NHS care and travel with one parent or caregiver under the scheme, which was announced by the UK government earlier this month. Participants in the arrangement told The National the Gazan children in greatest need are first selected by doctors and then given permission to travel by the Cogat bureaucracy in Israel's Ministry of Defence, which co-ordinates their travel with the World Health Organisation (WHO). The UK can evacuate children who are already on the WHO's list, the source explained. But there are concerns that the most urgent cases – such as severe burns – will be not make it to the UK's selection, as the Home Office requires the children to travel to Jordan or Egypt to have their biometric details processed for their visa. Children approved for medical evacuation by the Israeli authorities exit Gaza through the border crossings to Israel, where they are then evacuated to the country where they will be treated. But the UK's biometric requirements mean they will also need to make the stopover in Amman or Cairo. The Home Office and Department of Health and Social Care have been contacted for comment. This process has excluded Palestinian children from treatment in the UK in the past, according to Omar Din, a UK medical professional who has been co-ordinating medical evacuations for Palestinian children to Europe. Earlier this year the UK responded to calls to evacuate Hatem, a two-year old orphan with 35 per cent burns, and Karam, a baby who suffered from an easily treatable birth defect. But it then acted too slowly, and Italy took the children instead, alongside 15 others, in an emergency evacuation on June 11. Italy has waived its biometric requirement and brought over 180 children and adults from Gaza in 14 evacuations. MPs called on the UK government to bring the sick children 'without delay' this week, as the humanitarian crisis escalates and famine has been declared. Among their demands was to 'waive the biometric requirements for evacuees under this scheme', in a letter signed by 96 cross-party MPs. 'The requirement for biometrics as a prerequisite to issue visas remains a major barrier, given that the only authorised biometrics centre in Gaza closed in October 2023,' the group warned. 'We urge you to waive biometric requirements for evacuees under this scheme and permit applications to be completed after departure from Gaza.' They also said it was 'vital' for the children's carers or parents to accompany them to the UK and be with them during treatment. 'There is clear medical evidence to suggest their presence can positively impact the recovery of sick or injured children,' they said. The UK government has said it will allow one caregiver to travel with the child. The UK's decision to treat Palestinian children on the NHS came after over 18 months of campaigning from MPs and British doctors. So far, 7,528 patients have been evacuated from Gaza for medical treatment, according to the WHO. But only three are currently being treated in the UK. Since July 2024, the treatment has been mainly for trauma (712 cases) and cancer (660), followed by eye disorders (250), birth defects (240) and heart disease (208). Project Pure Hope had raised the funds to treat up to 50 children privately but it took them 19 months to get their first visa. It now has three Palestinian children in the UK for private treatment and hopes to continue running its scheme in parallel to the UK government.
Zawya
20 hours ago
- Zawya
Africa Must Reduce Reliance on Imported Medicines, World Health Organization (WHO) Urges at Regional Good Manufacturing Practices (GMP) Training Workshop
Africa must prioritize pharmaceutical self-reliance by boosting local medicine production rooted in global quality standards, said Dr Owen Laws Kaluwa, WHO Representative to Ethiopia, in a keynote address delivered at a regional training workshop on Good Manufacturing Practices (GMP) held in Addis Ababa. The two-day hands-on workshop, held from 22–23 July 2025, brought together 26 participants from National Regulatory Authorities (NRAs) and pharmaceutical manufacturers across seven East African Community (EAC) member states. It was jointly organized by the Local Production and Assistance Unit in WHO Headquarters, the WHO Regional Office for Africa (AFRO), and the WHO Country Office in Ethiopia, with financial support from The Global Fund to Fight AIDS, Tuberculosis and Malaria. Designed to strengthen technical capacities in GMP implementation, the training offered a mix of instructional content and case-based learning. Core topics included Quality Management Systems, Quality Risk Management, Corrective and Preventive Actions (CAPA), data integrity, validation practices, and management of critical utility systems such as water and HVAC. The approach strengthened practical skills in complying with current WHO GMP standards and fostered active collaboration between regulatory bodies and industry professionals, enhancing mutual understanding and shared responsibility for quality-assured pharmaceutical production. Dr Jicui Dong, Unit Head of the WHO Local Production and Assistance Unit, remarked 'Compliance with current GMP standards needs both theoretical knowledge and practical skills. It is encouraging to see the commitment of pharmaceutical manufacturers within this region to invest in workforce development and ensure local production of quality pharmaceuticals.' Opening the workshop, Mr Dejene Daba, Head of the Medicine Manufacturers Inspection and Enforcement Desk at the Ethiopian Food and Drug Authority (EFDA), reaffirmed the agency's commitment to supporting manufacturers and attaining WHO Maturity Level 3 regulatory status—a benchmark for robust regulatory systems. Dr Kaluwa underscored that reliance on imported medicines continues to pose significant health security risks for African countries, particularly in times of global supply chain disruptions. 'Enhancing local pharmaceutical production is not only a strategic health priority but also an economic and political imperative,' he said. The workshop represents a concrete step toward building regional capabilities to meet international manufacturing standards, aligning with broader continental goals such as the African Union and Africa CDC. Distributed by APO Group on behalf of World Health Organization (WHO) - Ethiopia.
